Mackenzie Financial
FLGT icon

Mackenzie Financial’s Fulgent Genetics FLGT Stock Holding History

Mackenzie Financial’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$220K Hold
10,730
– – ﹤0.01% 1476
2026
Q1 		$171K Sell
10,730
-1,296
-11% -$28.1K ﹤0.01% 1373
2025
Q4 		$318K Sell
12,026
-129
-1% -$3.35K ﹤0.01% 1363
2025
Q3 		$275K Buy
12,155
+1,220
+11% +$25.1K ﹤0.01% 1455
2025
Q2 		$217K Buy
+10,935
New +$213K ﹤0.01% 1524

Other funds holding FLGT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Mackenzie Financial's FLGT Position: Q2 2026 in Review

Mackenzie Financial held its Fulgent Genetics (FLGT) position steady in Q2 2026 at 10,730 shares worth $220K. The position accounts for ﹤0.01% of the portfolio, ranked #1476.

Mackenzie Financial first reported a position in FLGT in Q2 2025 and has held it in 5 quarters since. The position peaked at $318K in Q4 2025. 142 funds tracked by Wall St. Rank hold FLGT as of Q2 2026.

  • Mackenzie Financial held 10,730 shares of Fulgent Genetics worth $220K as of Q2 2026.
  • Mackenzie Financial left its Fulgent Genetics share count unchanged in Q2 2026.
  • Fulgent Genetics made up ﹤0.01% of Mackenzie Financial's portfolio in Q2 2026, its #1476 holding.
  • Mackenzie Financial first reported a position in Fulgent Genetics in Q2 2025 and has held it in 5 quarters since.
  • Mackenzie Financial's Fulgent Genetics position peaked at $318K in Q4 2025.
  • 142 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2026.

Based on Mackenzie Financial's 13F filing for Q2 2026, filed 13 Aug 2026.